H1B Report
Side-by-side comparison

AustarPharma, LLC vs Deloitte Consulting LLP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
AustarPharma, LLC
NJRank #FEIN 51-0523899
Entity B
Deloitte Consulting LLP
PARank #4FEIN 06-1454513

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricAustarPharma, LLCDeloitte Consulting LLP
Total filings6279,212
Certified %91.94%98.22%
Denied %8.06%1.09%
Withdrawn %0.00%0.61%
Cert-withdrawn %0.00%0.07%
Rank#4
Active yearsFY2010–FY2024FY2010–FY2026
Worksite stateNJPA

Outcomes — AustarPharma, LLC

DOL case-status mix.

Outcome breakdown: Certified 91.9%, Denied 8.1%
Outcome breakdown
OutcomeShare
Certified91.9%
Denied8.1%
Certified91.9%
Denied8.1%

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

AustarPharma, LLC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102
FY20111
FY20125
FY20136
FY201412
FY20158
FY20167
FY20178
FY20186
FY20196
FY20200
FY20210
FY20220
FY20230
FY20241
FY20250
FY20260
Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,357
FY20113,610
FY20124,667
FY20136,024
FY20146,873
FY20157,505
FY20167,371
FY20177,040
FY201816,029
FY20197,724
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20261,792

Top 5 occupations — AustarPharma, LLC

Top 5 occupations — Deloitte Consulting LLP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.
AustarPharma, LLC vs Deloitte Consulting LLP — H-1B Sponsor Comparison · H1B Report